PortfoliosLab logoPortfoliosLab logo
TELO vs. ENVB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TELO vs. ENVB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Telomir Pharmaceuticals, Inc (TELO) and Enveric Biosciences Inc (ENVB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TELO achieves a -4.51% return, which is significantly higher than ENVB's -46.01% return.


TELO

1D
3.25%
1M
-4.51%
YTD
-4.51%
6M
-6.62%
1Y
-39.81%
3Y*
5Y*
10Y*

ENVB

1D
-1.01%
1M
-43.68%
YTD
-46.01%
6M
-67.92%
1Y
-87.34%
3Y*
-86.14%
5Y*
-84.40%
10Y*
-74.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TELO vs. ENVB - Yearly Performance Comparison


2026 (YTD)20252024
TELO
Telomir Pharmaceuticals, Inc
-4.51%-67.72%-17.60%
ENVB
Enveric Biosciences Inc
-46.01%-94.37%-53.47%

Correlation

The correlation between TELO and ENVB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Feb 12, 2024

0.16

Fundamentals

Market Cap

TELO:

$43.66M

ENVB:

$2.96M

EPS

TELO:

-$0.28

ENVB:

-$10.60

PB Ratio

TELO:

8.80

ENVB:

0.58

Total Revenue (TTM)

TELO:

$0.00

ENVB:

$0.00

Gross Profit (TTM)

TELO:

$0.00

ENVB:

-$119.83K

EBITDA (TTM)

TELO:

-$8.30M

ENVB:

-$8.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TELO vs. ENVB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TELO
TELO Risk / Return Rank: 2525
Overall Rank
TELO Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
TELO Sortino Ratio Rank: 3232
Sortino Ratio Rank
TELO Omega Ratio Rank: 3131
Omega Ratio Rank
TELO Calmar Ratio Rank: 1313
Calmar Ratio Rank
TELO Martin Ratio Rank: 2020
Martin Ratio Rank

ENVB
ENVB Risk / Return Rank: 1212
Overall Rank
ENVB Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
ENVB Sortino Ratio Rank: 1414
Sortino Ratio Rank
ENVB Omega Ratio Rank: 1414
Omega Ratio Rank
ENVB Calmar Ratio Rank: 33
Calmar Ratio Rank
ENVB Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TELO vs. ENVB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Telomir Pharmaceuticals, Inc (TELO) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TELOENVBDifference
Sharpe ratioReturn per unit of total volatility

+0.16

Sortino ratioReturn per unit of downside risk

+0.86

Omega ratioGain probability vs. loss probability

1.01

0.90

+0.11

Calmar ratioReturn relative to maximum drawdown

-0.76

-0.97

+0.22

Martin ratioReturn relative to average drawdown

-1.03

-1.34

+0.32

TELO vs. ENVB - Sharpe Ratio Comparison

The current TELO Sharpe Ratio is -0.34, which is higher than the ENVB Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of TELO and ENVB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TELOENVBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.34

-0.50

+0.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.54

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

-0.46

+0.12

Drawdowns

TELO vs. ENVB - Drawdown Comparison

The maximum TELO drawdown since its inception was -90.92%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TELO and ENVB.


Loading charts...

Drawdown Indicators


TELOENVBDifference

Max Drawdown

Largest peak-to-trough decline

-90.92%

-100.00%

+9.08%

Max Drawdown (1Y)

Largest decline over 1 year

-52.84%

-89.71%

+36.87%

Max Drawdown (3Y)

Largest decline over 3 years

-99.79%

Max Drawdown (5Y)

Largest decline over 5 years

-99.99%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-89.33%

-100.00%

+10.67%

Average Drawdown

Average peak-to-trough decline

-71.02%

-86.07%

+15.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.85%

65.01%

-26.16%

Volatility

TELO vs. ENVB - Volatility Comparison

The current volatility for Telomir Pharmaceuticals, Inc (TELO) is 12.45%, while Enveric Biosciences Inc (ENVB) has a volatility of 22.37%. This indicates that TELO experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TELOENVBDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.45%

22.37%

-9.92%

Volatility (6M)

Calculated over the trailing 6-month period

41.64%

135.91%

-94.27%

Volatility (1Y)

Calculated over the trailing 1-year period

116.78%

174.17%

-57.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

132.37%

155.99%

-23.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

132.37%

164.54%

-32.17%

Dividends

TELO vs. ENVB - Dividend Comparison

Neither TELO nor ENVB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TELO vs. ENVB - Financials Comparison

This section allows you to compare key financial metrics between Telomir Pharmaceuticals, Inc and Enveric Biosciences Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober202600
(TELO) Total Revenue
(ENVB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TELO and ENVB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ENVB has higher volatility (22.37%) compared to TELO (12.45%). In terms of maximum drawdown, TELO dropped -90.92% vs ENVB's -100.00%.

TELO currently has the higher Sharpe Ratio (-0.34 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TELO and ENVB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer